Newz Quest

Independent voices. Trusted news. In two languages…

N Shorts

New Experimental Drug Enlicitide May Cut “Bad” Cholesterol By Up To 60%

N Shorts
New Experimental Drug Enlicitide May Cut "Bad" Cholesterol By Up To 60%
A new daily oral medication, enlicitide, has shown reductions in LDL cholesterol of up to 60% in a late-stage Phase 3 trial, matching the efficacy of injectable PCSK9 inhibitors.

Technically enhanced content presented under fair use in public-interest journalism.

Listen:

↓ Download Audio

Vanshika

Meet Vanshika, a promising trainee at Newzquest.in, who plays a vital role in managing the news site’s operations with dedication and precision. With a strong interest in economics and data-driven insights, Vanshika focuses on analyzing economic trends to provide clear and timely news reporting. Her analytical mindset and eagerness to learn have made her an important contributor to the editorial process, enhancing content quality and aligning with the diverse expectations of Newzquest’s audience. Committed to continual growth, Vanshika actively deepens her understanding of the news landscape to offer nuanced insights on critical issues, helping foster a well-informed community.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Verified by MonsterInsights